14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:FPRX
Delisted

Five Prime Therapeutics Stock Price (Quote)

$38.00
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $38.00 $38.00 Friday, 27th May 2022 FPRX stock ended at $38.00. During the day the stock fluctuated 0% from a day low at $38.00 to a day high of $38.00.
90 days $38.00 $38.00
52 weeks $38.00 $38.00

Historical Five Prime Therapeutics prices

Date Open High Low Close Volume
Aug 12, 2021 $38.00 $38.00 $38.00 $38.00 0
Aug 11, 2021 $38.00 $38.00 $38.00 $38.00 0
Aug 10, 2021 $38.00 $38.00 $38.00 $38.00 0
Aug 09, 2021 $38.00 $38.00 $38.00 $38.00 0
Aug 06, 2021 $38.00 $38.00 $38.00 $38.00 0
Aug 05, 2021 $38.00 $38.00 $38.00 $38.00 0
Aug 04, 2021 $38.00 $38.00 $38.00 $38.00 0
Aug 03, 2021 $38.00 $38.00 $38.00 $38.00 0
Aug 02, 2021 $38.00 $38.00 $38.00 $38.00 0
Jul 30, 2021 $38.00 $38.00 $38.00 $38.00 0
Jul 29, 2021 $38.00 $38.00 $38.00 $38.00 0
Jul 28, 2021 $38.00 $38.00 $38.00 $38.00 0
Jul 27, 2021 $38.00 $38.00 $38.00 $38.00 0
Jul 26, 2021 $38.00 $38.00 $38.00 $38.00 0
Jul 23, 2021 $38.00 $38.00 $38.00 $38.00 0
Jul 22, 2021 $38.00 $38.00 $38.00 $38.00 0
Jul 21, 2021 $38.00 $38.00 $38.00 $38.00 0
Jul 20, 2021 $38.00 $38.00 $38.00 $38.00 0
Jul 19, 2021 $38.00 $38.00 $38.00 $38.00 0
Jul 16, 2021 $38.00 $38.00 $38.00 $38.00 0
Jul 15, 2021 $38.00 $38.00 $38.00 $38.00 0
Jul 14, 2021 $38.00 $38.00 $38.00 $38.00 0
Jul 13, 2021 $38.00 $38.00 $38.00 $38.00 0
Jul 12, 2021 $38.00 $38.00 $38.00 $38.00 0
Jul 09, 2021 $38.00 $38.00 $38.00 $38.00 0
Click to get the best stock tips daily for free!

About Five Prime Therapeutics

Five Prime Therapeutics Five Prime Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of protein therapeutics that block cancer and inflammatory disease processes in the United States. The company’s product candidates include FPA008, an antibody that inhibits colony stimulating factor-1 receptor and is in Phase Ia/Ib clinical trials for the treatment of various cancers in combination with nivolumab; and is in Phase I/II... FPRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT